Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outpatient cisplatin + 5-fluorouracil + leucovorin for advanced head and neck or upper esophageal squamous cell carcinoma
ISRCTN09659857Phase 2Completed
- Sponsor
- Hospital Estadual Mário Covas
- Start
- Jan 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin, fluorouracil and folinic acid in head and neck squamous cell carcinoma (HNSCC) and Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Hospital Estadual Mário Covas. Primary endpoints: Quality of life, Toxicity and 2 more. Started Jan 2005; status: completed.
02
Drugs
cisplatinfluorouracilfolinic acid
03
Conditions
head and neck squamous cell carcinoma (HNSCC)Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on ISRCTN09659857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN09659857.